{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:19:35Z","timestamp":1789924775838,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"military medical science youth funding","award":["13QNP086"],"award-info":[{"award-number":["13QNP086"]}]},{"name":"309 Hospital","award":["2013ZD-001"],"award-info":[{"award-number":["2013ZD-001"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jneuroim.2015.08.013","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T18:10:57Z","timestamp":1440526257000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Aberrant decrease of microRNA19b regulates TSLP expression and contributes to Th17 cells development in myasthenia gravis related thymomas"],"prefix":"10.1016","volume":"288","author":[{"given":"Zhongkui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongning","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.08.013_bb0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4 (+) CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0015","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2013.03.010","article-title":"Etiology of myasthenia gravis: innate immunity signature in pathological thymus","volume":"12","author":"Cavalcante","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10875-012-9834-5","article-title":"MiR-320a is downregulated in patients with myasthenia gravis and modulates inflammatory cytokines production by targeting mitogen-activated protein kinase 1","volume":"33","author":"Cheng","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2013.12.018","article-title":"Thymoma-associated myasthenia gravis: on the search for a pathogen signature","volume":"52","author":"Cufi","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20101876","article-title":"Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphpoietin production and reduced survival in pancreatic cancer","volume":"208","author":"De Monte","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0040","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1212\/01.WNL.0000032502.89361.0C","article-title":"Thymoma in patients with MG: characteristics and long-term outcome","volume":"59","author":"Evoli","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","article-title":"Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study","volume":"44","author":"Filosso","year":"2013","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.07.003","article-title":"Altered let-7 expression in myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells","volume":"14","author":"Jiang","year":"2012","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jneuroim.2015.08.013_bb0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2007.03.081","article-title":"A possible role for TSLP in inflammatory arthritis","volume":"357","author":"Koyama","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0060","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1158\/0008-5472.CAN-06-4478","article-title":"Oncogenic potential of the miR-106\u2013363 cluster and its implication in human T-cell leukemia","volume":"67","author":"Landais","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0075","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anticytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2008.04.001","article-title":"miRiad roles for the miR-17\u201392 cluster in development and disease","volume":"133","author":"Mendell","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0095","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0025-6196(12)60907-0","article-title":"Thymoma","volume":"68","author":"Morgenthaler","year":"1993","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0100","article-title":"miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells","volume":"5 8201","author":"Ohira","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0105","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.4049\/jimmunol.1100463","article-title":"Thymic stromal lymphopoietinis a key mediator of breast cancer progression","volume":"186","author":"Olkhanud","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004150050604","article-title":"Muscle autoantibodies in subgroups of myasthenia gravis patients","volume":"247","author":"Romi","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2015.08.013_bb0125","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/mi.2011.64","article-title":"Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis","volume":"5","author":"Spadoni","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0130","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/ana.20340","article-title":"Selective loss of regulatory T cells in thymomas","volume":"56","author":"Str\u00f6bel","year":"2004","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2015.08.013_bb0135","first-page":"439","article-title":"The investigation of expression levels of TSLP in thymus and phenotype of CD4CD25Foxp3Treg cells in patients with myasthenia gravis","volume":"19","author":"Sun","year":"2012","journal-title":"Chin. J. Neuroimmunol. Neurol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0140","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2004"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1000-1948(09)60017-4","article-title":"Reduction of natural regulatory T cells in thymomas accompanying myasthenia gravis and its possible association with Foxp3 and thymic stromal lymphopoietin","volume":"24","author":"Wang","year":"2009","journal-title":"J. Med. Coll. PLA"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1620\/tjem.232.85","article-title":"Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer","volume":"232","author":"Wu","year":"2014","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2009.02.038","article-title":"MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11010-013-1679-6","article-title":"MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion","volume":"380","author":"Yu","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0170","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature05590","article-title":"Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis","volume":"446","author":"Zaph","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2015.08.013_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-404717-4.00004-4","article-title":"The biology of thymic stromal lymphopoietin (TSLP)","volume":"66","author":"Ziegler","year":"2013","journal-title":"Adv. Pharmacol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:08Z","timestamp":1759047968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815300278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":35,"alternative-id":["S0165572815300278"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.08.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant decrease of microRNA19b regulates TSLP expression and contributes to Th17 cells development in myasthenia gravis related thymomas","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}